kynostatin 227 has been researched along with 3-amino-2-hydroxy-4-phenylbutanoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erickson, J; Ford, H; Gulnik, S; Hayashi, H; Kageyama, S; Mimoto, T; Murakawa, Y; Nomizu, M; Shirasaka, T; Takada, K | 1 |
| Itoh, E; Shibata, N; Terashima, S | 1 |
2 other study(ies) available for kynostatin 227 and 3-amino-2-hydroxy-4-phenylbutanoic acid
| Article | Year |
|---|---|
In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine.
Topics: Antiviral Agents; Cell Line; Cytopathogenic Effect, Viral; Drug Resistance, Microbial; Gene Products, gag; HIV; HIV Protease Inhibitors; HIV-1; HIV-2; Humans; Oligopeptides; Phenylbutyrates; Protein Precursors; Protein Processing, Post-Translational; Radioimmunoprecipitation Assay; Zidovudine | 1993 |
Practical synthesis of (2s,3s)-3-amino-2-hydroxy-4-phenylbutyric acid, a key component of HIV protease inhibitors.
Topics: Anti-HIV Agents; Carbamates; Furans; HIV Protease Inhibitors; Nitriles; Oligopeptides; Phenylbutyrates; Stereoisomerism; Sulfonamides | 1998 |